AiCuris Anti-infective Cures AG Email Format

Biotechnology ResearchNorth Rhine-westphalia, Germany51-200 Employees

AiCuris Anti-infective Cures AG is a biotechnology research company based in Wuppertal, North Rhine-Westphalia, Germany. Its flagship therapy PREVYMIS targets cytomegalovirus infection in a defined group of transplant recipients and is marketed through a partnership with MSD. The company is pursuing a broader pipeline, including Pritelivir, a Phase 3 candidate designed to treat recurrent and resistant herpes simplex virus infections in immunocompromised patients.

AiCuris operates in the biotechnology research industry and collaborates with MSD to bring treatments to patients at risk from severe infections. Recent activity includes presenting new clinical data at the 2025 ID Week Annual Meeting, illustrating ongoing work to advance its candidates.

Sign up for free to view info

Company overview Employee directory